Acuta Capital Partners, LLC Surface Oncology, Inc. Transaction History

Acuta Capital Partners, LLC

  • $92.9 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$7.25 - $13.82 $7.25 Million - $13.8 Million
-999,500 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$6.87 - $10.48 $607,995 - $927,480
-88,500 Reduced 8.13%
999,500 $9.24 Million
Q3 2020

Nov 16, 2020
BUY
$5.06 - $7.23 $4.37 Million - $6.24 Million
863,000 Added 383.56%
1,088,000 $7.51 Million
Q2 2020

Aug 14, 2020
BUY
$1.57 - $6.56 $353,250 - $1.48 Million
225,000 New
225,000 $1.48 Million

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0
View Full List

About Surface Oncology, Inc.

SURF Quotes by TradingView
  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email